30 likes | 126 Views
The article delves into the current landscape of genetic testing for breast cancer, exploring the benefits, ethical considerations, and professional opinions surrounding this practice. While companies like Myriad champion the testing, experts like Judy Garber advise caution and proper guidance before undertaking the "Big" Test.
E N D
BREAST CANCER: TO TEST OR NOT TO TEST?
What’s Current? On the surface, Breast Cancer testing on a genetic level, may seem highly advantageous. To know one's status and possible level of predisposition, is a basic right; both for women as well as men. However its benefits are highly subject to opinion in both professional and personal settings. Myriad, a leading company in breast cancer drugs and research, pioneers heavily for this cause. One of their television ads portrait a distressed women, "Breast cancer runs in my family. BRACAnalysis is a blood test that's helped thousands find out their risk for hereditary breast and ovarian cancer. I realized I could choose to find ways to help reduce my risk now." Other professionals in the field are skeptical and believe that the situation is more complexed. Judy Garber, a genetics specialist at the Dana-Farber Cancer Institute, believes that not all persons should have genetic testing done and if so must be done with a qualified health professional throughout the entire process. She concedes, "There are tremendous implications.“